FDA Adopts Final ICH M7(R1) Mutagenic Carcinogen Guideline

Drug Industry Daily
A A
Potential or actual impurities in drugs should be studied for their mutagenic properties, according to a revision to an ICH guideline addendum on mutagenic carcinogens, now adopted by the FDA.

To View This Article:

Login

Subscribe To Drug Industry Daily